Neil Josephson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Iambic Therapeutics Announces First Patient Dosed in Phase 1 Clinical Study of IAM1363, a Highly Selective HER2 Inhibitor for the Treatment of Solid Tumors

Iambic Therapeutics Announces First Patient Dosed in Phase 1 Clinical Study of IAM1363, a Highly Selective HER2 Inhibitor for the Treatment of Solid Tumors
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoNeil josephsonProduct serviceTherapeutics announces first patient dosedHighly selectiveChief medical officerAlexander spiraVirginia cancer specialistsIambic therapeutics

Iambic Therapeutics Expands Leadership Team With the Appointment of Neil Josephson, MD as Chief Medical Officer

Iambic Therapeutics Expands Leadership Team With the Appointment of Neil Josephson, MD as Chief Medical Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesLa jollaJason glashowTom millerNeil josephsonJazz pharmaceuticalsGlashow strategic communications for iambic therapeuticsUniversity of washingtonColumbia universityDartmouth collegeDivision of hematologyCompany clinical advisory boardJackie wallingClinical advisoryChief medical officerIambic therapeutics

Takeda welcomes new leader—Chutes & Ladders

Takeda welcomes new leader—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

New jerseyUnited statesSan diegoMaartje verschuurAstellas pharmaEric adlerStuart milsteinKerry benenatoNeil josephsonChris emeryAmy burroughsGabrielle massonNicolas chornetasJoanne bryceJean franchiRoche genentech

Iambic Therapeutics Expands Leadership Team With the Appointment of Neil Josephson, MD as Chief Medi

Interim CMO Dr. Jackie Walling to join Iambic’s Clinical Advisory BoardSAN DIEGO (BUSINESS WIRE) Iambic Therapeutics, a biotechnology company developing novel therapeutics using its AI-driven discovery platform, today announced the appointment of oncologist and industry veteran Neil Josephson, M.D., as its Chief M.

United statesLa jollaNeil josephsonTom millerColumbia universityCompany clinical advisory boardDivision of hematologyUniversity of washingtonJazz pharmaceuticalsDartmouth collegeJackie wallingClinical advisoryIambic therapeuticsChief medical officerIambic therapeuticHodgkin lymphoma

Investor Sentiment Rushes Back For Zymeworks After Hedge Fund Buys More Shares

Shares of cancer and disease focused biotech Zymeworks (NASDAQ:ZYME) strengthened 15.80% in trading on Friday

San franciscoUnited statesChrist astleNeil josephsonHenry singletonAkash tewariRedmile groupExcess cash flow value fundsFull henry singleton seriesChief medical officer neil josephsonShort squeeze score